Review evaluates surgical strategies and controversies in managing gastric cancer.
During the past decades, despite considerable improvements in the management of gastric cancer, surgery remains the main curative treatment. However, there is still debate about the extent of gastrectomy and lymphadenectomy, multivisceral resection, the requirement for reoperation for specimens with positive margins, the selection of neoadjuvant treatment and the management strategy of early gastric cancer. This review is to evaluate the above issues based on the reported prospective and retrospective studies.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: